| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8789930 | Urologic Oncology: Seminars and Original Investigations | 2018 | 9 Pages |
Abstract
SERPING1 may play an important role in PCa and can be serve as a novel marker in diagnosis and prognostic prediction in PCa. In addition, levels of SERPING1 can help identify low-risk prostate to provide reference for patients with PCa to accept active surveillance and reduce overtreatment.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Shengmeng M.M., Tao M.D., Ph.D., Wanhua M.M., Xianju M.M., Yiming M.M., Dingjun M.D., Ph.D., Qiong M.M., Xiaoming M.M., Chunhao M.M., Zean M.M., Zhenghui M.D., Ph.D., Hai M.D., Ph.D.,